ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $159,853,000 | -9.1% | 12,850,000 | 0.0% | 44.03% | +8.7% |
| Q3 2016 | $175,916,000 | +85.3% | 12,850,000 | 0.0% | 40.51% | +50.3% |
| Q2 2016 | $94,961,000 | +15.6% | 12,850,000 | 0.0% | 26.95% | +49.0% |
| Q1 2016 | $82,111,000 | +2.2% | 12,850,000 | 0.0% | 18.09% | +15.9% |
| Q4 2015 | $80,313,000 | +7.0% | 12,850,000 | 0.0% | 15.61% | -15.8% |
| Q3 2015 | $75,044,000 | -29.4% | 12,850,000 | 0.0% | 18.53% | -24.2% |
| Q2 2015 | $106,270,000 | +0.4% | 12,850,000 | 0.0% | 24.46% | +9.5% |
| Q1 2015 | $105,884,000 | +19.9% | 12,850,000 | 0.0% | 22.34% | -28.5% |
| Q4 2014 | $88,280,000 | +27.2% | 12,850,000 | 0.0% | 31.25% | +16.6% |
| Q3 2014 | $69,390,000 | -9.2% | 12,850,000 | +7.1% | 26.80% | +3.1% |
| Q2 2014 | $76,440,000 | -21.0% | 12,000,000 | 0.0% | 25.99% | -21.9% |
| Q1 2014 | $96,720,000 | +18.2% | 12,000,000 | 0.0% | 33.30% | +8.7% |
| Q4 2013 | $81,840,000 | – | 12,000,000 | – | 30.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |